Response date: 9/17/2020
Harnessing Enzymatic Activity for Lifesaving Remedies (HEALR)
DARPA is soliciting innovative proposals to develop (1) new therapeutics
against Department of Defense (DoD)-priority bacterial threats that leverage
host-driven protein degradation or deactivation pathways; and (2) a platform
capability to rapidly develop, screen, and optimize therapeutics against
emerging bacterial threats.
- DOWNLOAD HR001120S0052: FAQ